| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_959bc5e33766e46c877f5a28723c391a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 |
| filingDate |
2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee8ef3090961f8f9013865c6427670e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b79d2058619f33333540740aa37a8c0d |
| publicationDate |
2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013084185-A1 |
| titleOfInvention |
Use of silver (i) complexes as anticancer agents |
| abstract |
The present invention relates to the use of silver(l) monophosphine complexes as Active Pharmaceutical Ingredients (API's), including anticancer agents, for the treatment, diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109705158-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109705158-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110028526-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110028526-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110041364-A |
| priorityDate |
2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |